Last reviewed · How we verify

BD03

SL VAXiGEN · Phase 1 active Biologic

At a glance

Generic nameBD03
SponsorSL VAXiGEN
ModalityBiologic
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results